Posted on 10/09/05
Expensive cancer drugs get approval
Two colorectal cancer drugs received Health Canada approval yesterday, opening the door for provincial governments to fund the costly medications.Avastin, a first-line treatment for incurable colorectal cancer, and Erbitux, which shrinks tumours in some patients, were approved for use against the second-biggest cause of cancer death in Canada, Health Canada spokeswoman Jirina Vlk confirmed yesterday.
The full text of this article has 827 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
